Search

Search Constraints

You searched for: Author/Creator Linehan, W. Marston

Search Results

11. Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement. Issue 21 (3rd August 2021)

12. Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276). Issue 10 (24th July 2017)

13. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early‐onset disease. Issue 7 (12th December 2018)

14. Intravitreous treatment of severe ocular von Hippel–Lindau disease using a combination of the VEGF inhibitor, ranibizumab and PDGF inhibitor, E10030: Results from a phase 1/2 clinical trial. (26th October 2021)

15. Loss of Folliculin Disrupts Hematopoietic Stem Cell Quiescence and Homeostasis Resulting in Bone Marrow Failure. (2nd February 2016)

16. Loss of Folliculin Disrupts Hematopoietic Stem Cell Quiescence and Homeostasis Resulting in Bone Marrow Failure. (2nd February 2016)

17. Magnetic resonance imaging (MRI)‐guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI‐based moulds. (7th June 2013)

18. MicroRNA‐204‐5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma. Issue 6 (24th May 2019)

19. MP33-06 PREDICTING RENAL TUMOR GROWTH IN VON HIPPEL-LINDAU (VHL) PATIENTS FROM MAGNETIC RESONANCE IMAGING (MRI) FEATURES: A PILOT STUDY OF THE KIDNEY IMAGING SURVEILLANCE SCORING SYSTEM (KISSS). (May 2022)

20. Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments. Issue 8 (17th April 2020)